坦德姆糖尿病护理 TNDM
$16.91 −$1.08 (-6.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $16.91 0.00%
开盘$15.83
昨收$17.99
当日区间$15.45 – $17.32
成交量5.88M
市值$1.18B
市盈率（TTM）–
股息率–
财报
财报日平均波动±17.2%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+32.7%
最差反应-35.2%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 6 Aug 2026 | After Market | ±16.7% | +19.11% | 超出定价预期 |
| 2026/Q1 | 7 May 2026 | After Market | ±19.2% | -16.19% | 符合区间 |
| 2025/Q4 | 19 Feb 2026 | After Market | ±18.0% | +32.67% | 超出定价预期 |
| 2025/Q3 | 6 Nov 2025 | After Market | ±21.7% | +21.98% | 超出定价预期 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±19.4% | -19.94% | 超出定价预期 |
| 2025/Q1 | 30 Apr 2025 | After Market | ±19.6% | +18.58% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±16.7% | -35.25% | 超出定价预期 |
| 2024/Q3 | 6 Nov 2024 | After Market | ±20.0% | -2.69% | 符合区间 |
| 2024/Q2 | 1 Aug 2024 | After Market | ±21.1% | +18.35% | 符合区间 |
| 2024/Q1 | 2 May 2024 | After Market | ±16.5% | +22.32% | 超出定价预期 |
| 2023/Q4 | 21 Feb 2024 | After Market | ±20.8% | +10.86% | 符合区间 |
| 2023/Q3 | 1 Nov 2023 | After Market | ±20.4% | -14.37% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±17.1% | +4.44% | 符合区间 |
| 2023/Q1 | 3 May 2023 | After Market | ±14.2% | -6.11% | 符合区间 |
| 2022/Q4 | 22 Feb 2023 | After Market | ±15.6% | -4.69% | 符合区间 |
| 2022/Q3 | 2 Nov 2022 | After Market | ±11.8% | -28.38% | 超出定价预期 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$254.56M+5.8% YoY
营业利润-$13.79M+56.7% YoY
净利润-$21.17M+59.6% YoY
摊薄每股收益-$0.31+60.3% YoY
自由现金流-$38.68M-146.3% YoY
经营现金流-$34.63M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率56.0%
营业利润率-4.4%
净利率-6.1%
净资产收益率-48.0%
资产收益率-6.2%
投入资本回报率-9.0%
流动比率3.18
负债/资产比率88.7%
现金及投资$456.00M
总负债$718.99M
净现金（净负债）-$262.99M
暂无评论——快来第一个聊聊 TNDM。